NUtraceutical TReatment for hYpercholesterolemia in HIV-infected Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 15, 2017

Primary Completion Date

November 15, 2017

Study Completion Date

November 30, 2017

Conditions
HypercholesterolemiaInflammationAtherosclerosis
Interventions
DIETARY_SUPPLEMENT

Nutraceutical combination (NC)

An oral NC (red yeast rice-derived monacolin K 3 mg, berberine 500 mg, policosanol 10 mg, astaxanthin 0.5 mg, folic acid 0.2 mg and coenzyme Q10 2 mg) one pill/day was administered for 3 months along with prosecution of standardized diet regimen

BEHAVIORAL

No nutraceutical combination (noNC)

Prosecution of standardized diet regimen for 3 months

All Listed Sponsors
lead

University Of Perugia

OTHER

NCT03470376 - NUtraceutical TReatment for hYpercholesterolemia in HIV-infected Patients | Biotech Hunter | Biotech Hunter